SPONSOR
Jiangsu Simcere Pharmaceutical Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Non-Muscle-Invasive Bladder Cancer (NMIBC)Healthy Adult ParticipantsHealth, Subjective
Jiangsu Simcere Pharmaceutical Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Non-Muscle-Invasive Bladder Cancer (NMIBC), Healthy Adult Participants, Health, Subjective.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jiangsu Simcere Pharmaceutical Co., Ltd.
How many clinical trials has Jiangsu Simcere Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Non-Muscle-Invasive Bladder Cancer (NMIBC), Healthy Adult Participants, Health, Subjective. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jiangsu Simcere Pharmaceutical Co., Ltd. research focus on?
Jiangsu Simcere Pharmaceutical Co., Ltd. clinical trials span Non-Muscle-Invasive Bladder Cancer (NMIBC), Healthy Adult Participants, Health, Subjective. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jiangsu Simcere Pharmaceutical Co., Ltd. clinical trial?
To participate in a Jiangsu Simcere Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jiangsu Simcere Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Jiangsu Simcere Pharmaceutical Co., Ltd.
NCT06186414 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
Non-Muscle-Invasive Bladder Cancer (NMIBC)
NCT07357610 Phase 1
Recruiting
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
Healthy Adult Participants
NCT07345364 Phase 1
Recruiting
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
Health, Subjective
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology